HALOZYME THERAPEUTICS, INC. Logo

HALOZYME THERAPEUTICS, INC.

Licenses a drug delivery platform to biopharma, converting IV drugs to subcutaneous injections.

HALO | NDAQ

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
12390 EL CAMINO REAL, 92130 SAN DIEGO
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Halozyme Therapeutics, Inc. is a biotechnology company focused on its proprietary drug delivery technology platform, ENHANZE®. This technology facilitates the subcutaneous (under-the-skin) delivery of injectable drugs and biologics that are often administered intravenously. Halozyme licenses its ENHANZE® technology to global biopharmaceutical companies, enabling them to develop new formulations of their therapies. This model aims to reinvent the patient experience by reducing treatment burden and shortening administration times, particularly in therapeutic areas such as oncology. The company's commercial portfolio is primarily built on royalties and milestone payments derived from its partners' sales of products utilizing the ENHANZE® platform.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all HALOZYME THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HALOZYME THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HALOZYME THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Exploring for uranium & REEs, critical minerals for the clean energy and tech sectors.
Canada BATT
DBV Technologies Logo
Developing non-invasive skin patch immunotherapy for severe food allergies like peanut and milk.
France DBV
DD GROUP Co.,Ltd. Logo
Operates a diverse portfolio of food service, amusement, and hotel brands.
Japan 3073
A nationwide network of studios offering modern wedding photography and wellness services.
Japan 7372
Dedem SpA Logo
Diversified group providing photo booths, amusement rides, 3D printing, and tech solutions.
Italy DDM
Dedicare Logo
European recruitment and staffing firm for healthcare, life science, and social work sectors.
Sweden DEDI
Delta-Fly Pharma, Inc. Logo
Develops innovative, gentle anticancer agents with reduced side effects for cancer patients.
Japan 4598
DENISON MINES CORP. Logo
Uranium exploration and development company advancing projects in Canada's Athabasca Basin.
United States of America DNN
DENTSU GROUP INC. Logo
Global advertising & marketing firm integrating tech and consulting for brand growth.
Japan 4324
DGA S.A. Logo
Consulting, training, and EU-funded project services for public and private organizations.
Poland DGA

Talk to a Data Expert

Have a question? We'll get back to you promptly.